Perigon Wealth Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$561K Buy
18,826
+3,109
+20% +$95.4K 0.01% 847
2026
Q2
$545K Buy
15,717
+4,914
+45% +$132K 0.01% 848
2026
Q1
$224K Sell
10,803
-3,817
-26% -$90.2K ﹤0.01% 1157
2025
Q4
$475K Buy
14,620
+982
+7% +$42.1K 0.01% 825
2025
Q3
$774K Sell
13,638
-792
-5% -$40.6K 0.02% 591
2025
Q2
$719K Sell
14,430
-2,019
-12% -$91.3K 0.02% 574
2025
Q1
$486K Buy
16,449
+2,521
+18% +$93.6K 0.01% 648
2024
Q4
$389K Buy
+13,928
New +$345K 0.01% 724

Other funds holding HIMS

Perigon Wealth Management's HIMS Position: Q3 2026 in Review

Perigon Wealth Management increased its Hims & Hers Health (HIMS) stake by 20% in Q3 2026, buying an estimated $95.4K and bringing the position to 18,826 shares worth $561K. The position accounts for 0.01% of the portfolio, ranked #847.

Perigon Wealth Management first reported a position in HIMS in Q4 2024 and has held it in 8 quarters since. The position peaked at $774K in Q3 2025. 80 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Perigon Wealth Management held 18,826 shares of Hims & Hers Health worth $561K as of Q3 2026.
  • Perigon Wealth Management bought 3,109 Hims & Hers Health shares in Q3 2026, an estimated $95.4K.
  • Hims & Hers Health made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #847 holding.
  • Perigon Wealth Management first reported a position in Hims & Hers Health in Q4 2024 and has held it in 8 quarters since.
  • Perigon Wealth Management's Hims & Hers Health position peaked at $774K in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.